Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-27 @ 6:06 AM
Study NCT ID:
NCT05815160
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-12-01
First Post:
2023-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Debio 0123 in Combination With Carboplatin and Etoposide in Adult Participants With Small Cell Lung Cancer That Recurred or Progressed After Previous Standard Platinum-Based Therapy
Sponsor:
Debiopharm International SA
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-02
Start Date Type:
ACTUAL
Primary Completion Date:
2026-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-02
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-09
First Submit QC Date:
None
Study First Post Date:
2023-04-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-28
Last Update Post Date:
2025-12-01
Last Update Post Date Type:
ESTIMATED